13D Management added 294,000 shares of Acadia Healthcare in the first quarter; the estimated trade value was $5.32 million.
The quarter-end position value for the new holding was $6.88 million.
The transaction represented an 8.25% shift in 13F reportable assets under management.
On May 15, 2026, 13D Management disclosed a new position in Acadia Healthcare (NASDAQ:ACHC), acquiring 294,000 shares in a trade estimated at $5.32 million based on quarterly average pricing.
According to a filing with the Securities and Exchange Commission dated May 15, 2026, 13D Management initiated a new position in Acadia Healthcare (NASDAQ:ACHC) by acquiring 294,000 shares. The estimated value of the trade, calculated using the average closing price for the first quarter of 2026, was $5.32 million. The quarter-end value of the holding was $6.88 million, reflecting the position’s valuation at the end of the period.
| Metric | Value |
|---|---|
| Revenue (TTM) | $3.37 billion |
| Net Income (TTM) | ($1.10 billion) |
| Price (as of market close May 14, 2026) | $26.80 |
Acadia Healthcare is a leading provider of behavioral healthcare services, operating hundreds of facilities and thousands of beds across the United States and Puerto Rico. The company's scale and diversified service offerings position it as a key player in the mental health and addiction treatment sector. Acadia Healthcare's extensive facility network and focus on specialized care support its competitive advantage in addressing growing behavioral health needs.
Acadia Healthcare shares have badly lagged the broader market over the past year, but they surged over 60% last quarter alone, and 13D Management made the company one of its largest disclosed positions immediately after establishing the stake.
The timing is notable because Acadia’s underlying business trends have improved. First-quarter revenue climbed 7.6% to $828.8 million, while same-facility revenue rose 7.3%, helped by higher patient volumes and stronger pricing. Adjusted EBITDA increased to $144.2 million from $134.2 million a year earlier, prompting management to raise its full-year adjusted EBITDA and earnings guidance. CEO Debbie Osteen thanked disciplined execution, strong patient volumes, and continued operating efficiencies for the strong performance.
The company also continues expanding capacity. Acadia added 82 newly licensed beds during the quarter and now operates roughly 275 facilities with approximately 12,400 beds across 40 states and Puerto Rico. If management can keep this up, the stock’s recent underperformance could start to look more like an opportunity than a warning sign.
Before you buy stock in Acadia Healthcare, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Acadia Healthcare wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!*
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 18, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Twilio. The Motley Fool recommends Pearson Plc. The Motley Fool has a disclosure policy.